Aktywność fizyczna i wybrane czynniki hormonalne, a ryzyko karcinogenezy

• Autorzy: Pyrzanowska J , Skierska E.

Warianty tytułu

EN

Physical activity, selected hormonal fectors and the risk of carcinogenesis

• Języki publikacji: PL

Abstrakty

PL

Złożony proces karcinogenezy podlega wpływom wielu czynników, które ułatwiają lub utrudniają inicjację i promocję procesów nowotworowych. Zmieniające się pod wpływem aktywności fizycznej stężenia hormonów mogą oddziaływać na środowisko wewnętrzne organizmu człowieka, modulując ryzyko pojawienia się transformacji nowotworowej. W pracy opisano wpływ aktywności fizycznej na profile: insuliny, insulinopodobnych czynników wzrostu (IGF), IGFBP, leptyny i steroidów płciowych oraz mechanizmy ich oddziaływania na procesy nowotworzenia.

Słowa kluczowe

PL

nowotwory; aktywnosc fizyczna; choroby czlowieka; hormony wzrostu; hormony plciowe; otylosc; czynniki rakotworcze; insulinoopornosc; leptyna; czynniki hormonalne; onkogeneza; insulina

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2006
• Tom: 33
• Numer: 4
• Opis fizyczny: s.336-346,bibliogr.

Twórcy

autor

Pyrzanowska J

• Akademia Wychowania Fizycznego, Warszawa

autor

Skierska E.

Bibliografia

• 1. Ali O., Cohen P., Lee K.: Epidemiology and biology of IGFBP-3 as an anti-cancer molecule. Horm. Metab. Res., 2003, 35, 11-12, 726.
• 2. Aparicio T., Guilmeau S., Goiot H., et al.: Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. Gastroenterology 2004, 126, 2, 499.
• 3. Austin H., Austin J., Partridge E., et al.: Endometrial cancer, obesity and body fat distribution. Cancer Res., 1991, 51, 568.
• 4. Barnard R., Aronson W., Tymchuk C., et al.: Prostate cancer: another aspect of the insulin-resistance syndrome? Obes. Rev., 2002, 3, 4, 303.
• 5. Bauman A.: Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003. J. Sci. Med. Sport., 2004, 7, Suppl 1, 6.
• 6. Bernstein L.: Epidemiology of endocrine-related risk factors for breast cancer. J. Mammary Gland. Biol. Neoplasia 2002, 7, 1, 3.
• 7. Borugian M., Sheps S., Kim-Sing C., et al.: Insulin, macronutrient intake and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? Cancer Epidemiol. Biomarkers Prev., 2004, 13, 7, 1163.
• 8. Byers T., Nestle M., McTiernan A., et al.: ACS guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin., 2002, 52, 2, 92.
• 9. Calle E., Rodriguez C., Walker-Thurmond K., et al.: Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med., 2003, 348, 17, 1625.
• 10. DePrimo S., Shinghal R., Vidanes G., et al.: Prevention of prostate cancer. Hematol. Oncol. Clin. North. Am., 2001, 15, 3, 445.
• 11. Enger S., Ross R., Paganini-Hill A., et al.: Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol. Biomark. Prev., 2000, 9, 7, 681.
• 12. Friedenreich C., Orenstein M.: Physical activity and cancer prevention: etiologie evidence and biological mechanisms. J. Nutr., 2002, 132, Suppl. 11, 3456S.
• 13. Friedenreich C.: Physical activity and breast cancer risk: the effect of menopausal status. Exerc. Sport Sci. Rev., 2004, 32, 4, 180.
• 14. Friedenreich C., McGregor S., Courneya K., et al.: Case-control study of lifetime total physical activity and prostate cancer risk. Am. J. Epidemiol., 2004, 159, 8, 740.
• 15. Gram I., Funkhouser E., Tabar L.: Moderate physical activity in relation to mammographic patterns. Canc. Epidemiol. Biomark. Prev., 1999, 8, 2, 117.
• 16. Hailey J., Maxwell E., Koukouras K., et al.: Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells. Mol. Cancer Ther., 2002, 1, 14, 1349.
• 17. Hardwick J., Van den Brink G., Offerhaus G., et al.: Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001, 121, 1, 79.
• 18. I-Min L.: Physical Activity and Cancer Prevention - Data from Epidemiologic Studies. Med. Sci. Sports Exerc., 2003, 35, 11, 1823.
• 19. Jenkins P., Bustin S.: Evidence for a link between IGF-1 and cancer. Eur. J. Endocrinol., 2004, 151, Suppl. 2, S017.
• 20. Jerome L., Shiry L., Leyland-Jones B.: Deregulation of the IGF axis in cancer : epidemiological evidence and potential therapeutic interventions. Endocrinol. Relat. Cancer 2003, 10, 4, 561.
• 21. Jerome L., Shiry L., Leyland-Jones B.: Anti-insulin-like growth factor strategies in breast cancer. Semin. Oncol., 2004, 31, 1 Suppl. 3, 54.
• 22. Lacey J., Potischman N., Madigan M., et al.: IGFs, IGFBPs, and endometrial cancer in postmenopausal women: results from a US case-control study. Cancer Epidemiol. Biomark. Prev., 2004, 13, 4, 607.
• 23. Lattika P., Pukkala E.: Relationship between the risk of breast cancer and physical activity. Sports Med., 1998, 26, 3, 133.
• 24. Lawlor D., Smith G., Ebrahim S.: Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women Heart and Health Study. Cancer Causes Control 2004, 15, 3, 267.
• 25. Levitt R., Buckley J., Blouin M., et al.: Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of IGFBP-3 expression. Biochem. Biophys. Res. Commun., 2004, 316, 2, 421.
• 26. Lutosławska G.: Leptyna - hormon tkanki tłuszczowej i jej rola w procesach metabolicznych. Med. Sport., 2002, 6, 3, 129.
• 27. Malin A., Dai Q., Yu H., et al.: Evaluation of the synergistic effect of insulin resistance and IGFs on the risk of breast carcinoma. Cancer 2004, 100, 4, 694.
• 28. Manetta J., Brun J., Fedou C., et al.: Serum levels of IGF- 1 and IGFBP-1 I IGFBP-3 in middle-aged and young athletes versus sedentary men: relationship for glucose disposal. Metabolism 2003, 52, 7, 821.
• 29. McTiernan A.: Behavioral Risk Factors in Breast Cancer: Can Risk Be Modified? Oncology 2003, 8, 4, 326.
• 30. Medina D.: Mammary developmental fate and breast cancer risk. Endocrine-related Cancer 2005, 12, 483.
• 31. Nassis G., Papantakou K., Skenderi K., et al.: Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin and inflammatory markers in overweight and obese girls. Metabolism 2005, 54, 11, 1472.
• 32. Oliveria S., I-Min L.: Is exercise beneficial in the prevention of prostate cancer? Sport Med. 1997, 23, 5, 271.
• 33. Patel A., Rodriguez C., Jacobs E., et al.: Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol. Biomark. Prev., 2005, 14, 1, 275.
• 34. Parker E., Folsom A.: Intentional weight loss and incidence of obesity-related cancers: the IOWA Women’s Health Study. Int. J. Obes. Relat. Metab. Disord., 2003, 27, 12, 1447.
• 35. Pierotti B., Altieri A., Talamini R., et al.: Lifetime physical activity and prostate cancer risk. Int. J. Cancer 2005, 114, 4, 639.
• 36. Quadrilatero J., Hoffman-Goetz L.: Physical activity and colon cancer. A systematic review of potential mechanisms. J. Sports Med. Phys. Fitness 2003, 43, 2, 121.
• 37. Sandhu M., Dunger D., Giovannucci E.: Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J. Natl. Cancer Inst., 2002, 94, 13, 972.
• 38. Schmitz K., Ahmed R., Yee D.: Effects of a 9-month strength training intervention on insulin, IGF-1, IGFBP-1 and IGFBP-3 in 30-50- year-old women. Cancer Epidemiol. Biomark. Prev., 2002, 11, 1597.
• 39. Sellers T., Kushi L., Potter J. et al.: Effect of family history, body fat distribution and reproductive factors on the risk of postmenopausal breast cancer. N. Engl. J. Med., 1992, 326, 20, 1323.
• 40. Steiner M., Raghow S.: Antiestrogens and SERMs reduce prostate cancer risk. World J. Urol., 2003, 21, 1, 31.
• 41. Tran T., Medline A., Bruce W: Insulin promotion of colon tumors in rats. Cancer Epidemiol. Biomark. Prev., 1996, 5, 12, 1013.
• 42. Warburton D., Nicol C., Bredin S.: Health benefits of physical activity: the evidence. CMAJ 2006, 174, 6, 801.
• 43. Westerlind K., Gibson K., Malone P., et al.: Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J. Bone Miner. Res., 1998, 13, 6, 1023.
• 44. Westerlind K.: Physical activity and cancer prevention - mechanisms. Med. Sci. Sports Exerc., 2003, 35, 11, 1834.
• 45. Wetterau L., Francis M., Ma L., et al.: IGF-1 stimulates telomerase activity in prostate cancer cell. J. Clin. Endocrinol. Metab., 2003, 88, 7, 3354.